How to translate text using browser tools
13 June 2024 THE MANAGEMENT OF LYMPHOPROLIFERATIVE NEOPLASIA IN FOUR NORTHERN SEA OTTERS (ENHYDRA LUTRIS KENYONI)
Michael S. McEntire, Karisa N. Tang, Matthew R. O'Connor, Martin Haulena
Author Affiliations +
Abstract

Lymphoproliferative neoplasia has been reported in both free-ranging sea otters and those in managed care, but little information is available on the management of this neoplastic disease in this species. This case series describes clinical lymphoma in four northern sea otters (Enhydra lutris kenyoni) in managed care. Two otters presented with Stage 5 lymphoma with evidence of hematologic spread resulting in leukemia. Two additional otters presented with Stage 3 disease. Immunophenotypes in these cases included disseminated large B-cell lymphoma and lymphoblastic lymphoma of potential T-cell origin. Cases were managed with multiagent chemotherapy protocols including prednisone, L-asparaginase, cyclophosphamide, vincristine, cytosine arabinoside, lomustine, and doxorubicin. Unique approaches included the use of a vascular access port in one case and development of an autologous vaccine in another. Survival time ranged from 81 to 409 days. Diagnosis, staging, and treatment with multiagent protocols is recommended for the management of lymphoma in sea otters.

Michael S. McEntire, Karisa N. Tang, Matthew R. O'Connor, and Martin Haulena "THE MANAGEMENT OF LYMPHOPROLIFERATIVE NEOPLASIA IN FOUR NORTHERN SEA OTTERS (ENHYDRA LUTRIS KENYONI)," Journal of Zoo and Wildlife Medicine 55(2), 511-520, (13 June 2024). https://doi.org/10.1638/2022-0096
Accepted: 9 February 2024; Published: 13 June 2024
RIGHTS & PERMISSIONS
Get copyright permission
Back to Top